These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Charting, navigating, and populating natural product chemical space for drug discovery. Lachance H; Wetzel S; Kumar K; Waldmann H J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178 [TBL] [Abstract][Full Text] [Related]
45. A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screening. Brown N; Zehender H; Azzaoui K; Schuffenhauer A; Mayr LM; Jacoby E J Biomol Screen; 2006 Mar; 11(2):123-30. PubMed ID: 16361695 [TBL] [Abstract][Full Text] [Related]
46. Data structures and computational tools for the extraction of SAR information from large compound sets. Wawer M; Lounkine E; Wassermann AM; Bajorath J Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243 [TBL] [Abstract][Full Text] [Related]
47. High-throughput virtual screening for drug discovery in parallel. Toledo-Sherman LM; Chen D Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617 [TBL] [Abstract][Full Text] [Related]
49. Computational chemistry-driven decision making in lead generation. Schnecke V; Boström J Drug Discov Today; 2006 Jan; 11(1-2):43-50. PubMed ID: 16478690 [TBL] [Abstract][Full Text] [Related]
50. Fragment analysis in small molecule discovery. Merlot C; Domine D; Church DJ Curr Opin Drug Discov Devel; 2002 May; 5(3):391-9. PubMed ID: 12058614 [TBL] [Abstract][Full Text] [Related]
51. Rethinking molecular similarity: comparing compounds on the basis of biological activity. Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495 [TBL] [Abstract][Full Text] [Related]
52. Chemical genomics as an emerging paradigm for postgenomic drug discovery. Salemme FR Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717 [TBL] [Abstract][Full Text] [Related]
54. Tackling the chemogenomic space by novel screening technologies. Mayr LM Ernst Schering Res Found Workshop; 2006; (58):111-73. PubMed ID: 16709002 [TBL] [Abstract][Full Text] [Related]
56. Reporting data from high-throughput screening of small-molecule libraries. Inglese J; Shamu CE; Guy RK Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769 [TBL] [Abstract][Full Text] [Related]
57. Combinatorial chemistry in drug discovery. Liu R; Li X; Lam KS Curr Opin Chem Biol; 2017 Jun; 38():117-126. PubMed ID: 28494316 [TBL] [Abstract][Full Text] [Related]
58. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind". Snowden M; Green DV Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571 [TBL] [Abstract][Full Text] [Related]
59. The academic pursuit of screening. Nat Chem Biol; 2007 Aug; 3(8):433. PubMed ID: 17637766 [TBL] [Abstract][Full Text] [Related]
60. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series. Duffy BC; Zhu L; Decornez H; Kitchen DB Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]